We also did not detect an increase in CCL3 and CCL4 antibodies in COVID-19 convalescents compared with healthy controls in the Lugano cohort at month 6, although the amount of corresponding chemokines was elevated in their plasma (Fig. 3a and Extended Data Fig. 5a). The gene discussed is CCL3; the disease is COVID-19.